Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives
  To view this article:
Existing subscribers please log in:
   Or select

Or become a subscriber

Click here to view
our current issue


Playing It Safe

As more companies develop antibody-drug conjugates, there is growing focus on the production complexities such as handling their cytotoxic aspect and the role of contract manufacturing organisations in ensuring quality control.

Dr Cynthia Wooge, SAFC (June 2014)

Keywords: Antibody-drug conjugates, Monoclonal antibodies, Highly potent active pharmaceutical ingredient, Cytotoxic molecule

    View full article    |    Back to Manufacturing section

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPT © 2021 Innovations in Pharmaceutical Technology | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |